Sanofi
SNY
SNY
670 hedge funds and large institutions have $13.7B invested in Sanofi in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 248 increasing their positions, 228 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.27% less ownership
Funds ownership: 21.4% → 20.13% (-1.3%)
5% less capital invested
Capital invested by funds: $14.5B → $13.7B (-$779M)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
670
Holding in Top 10
12
Calls
$99.3M
Puts
$65.6M
Top Buyers
| 1 | +$69M | |
| 2 | +$49.9M | |
| 3 | +$26.2M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$25.1M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$22.9M |
Top Sellers
| 1 | -$260M | |
| 2 | -$192M | |
| 3 | -$109M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$81.6M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$80.7M |